Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Heart failure in African Americans
Clyde W. Yancy
*
*
Corresponding author for this work
Medicine, Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
94
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Heart failure in African Americans'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Heart Failure
100%
African American
100%
Cardiovascular Disease
66%
United States
33%
Racial-ethnic
33%
Targeted Treatment
33%
Current Treatment
33%
Heart Disease
33%
Vasodilator
33%
Enhanced Awareness
33%
Unique Characteristics
33%
Special Populations
33%
Beta-blockers
33%
Angiotensin-converting Enzyme Inhibitor (ACEi)
33%
Angiotensin Receptor Antagonists
33%
Substantial Burden
33%
Population Increase
33%
Excess Burden
33%
Ethnic Majority
33%
Medicine and Dentistry
Congestive Heart Failure
100%
Cardiovascular Disease
66%
ACE Inhibitor
33%
Vasodilator Agent
33%
Angiotensin Receptor Antagonist
33%
Awareness
33%
Heart Disease
33%
Targeted Therapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Cardiovascular Disease
66%
Heart Disease
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Angiotensin Receptor Antagonist
33%
Vasodilator Agent
33%
Nursing and Health Professions
Congestive Heart Failure
100%
Cardiovascular Disease
66%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Heart Disease
33%
Angiotensin Receptor Antagonist
33%
Vasodilator Agent
33%